Vivi Ann Flørenes Melanoma and gynecologic cancer basic and translational research group

Group Leader:Vivi Ann Flørenes
Group Leader:
Vivi Ann Flørenes

Our aim is to identify biomarkers (genes, gene products and pathways) of importance for diagnosis and that have prognostic relevance in serous effusions, uterine sarcomas, vulvar cancer and melanoma. Furthermore, we aim to identify potential therapeutic targets and develop a screening platform facilitating clinical treatment decision.

Research projects

  • Chemoresistance-related markers in ovarian carcinoma
  • Mutation profiles in ovarian carcinoma
  • NGS and tumor heterogeneity in ovarian carcinoma
  • Diagnostic and prognostic markers in uterine sarcoma
  • Identification of novel prognostic factors and therapeutic targets in vulvar cancer
  • Development of an iPSC based model to study melanoma tumorigenesis
  • Development of an ex-vivo assay to evaluate clinical treatment response
  • Identification of mechanisms for treatment resistance in melanoma

Contact information
Group Leader Vivi Ann Flørenes, Department of Pathology, Tel: +47 22 78 2433